Subgroup Analysis of Topical Tranexamic Acid in Total Knee Arthroplasty


  • John Tuttle, MD
  • Walter Anazonwu, BS
  • Lee Rubin, MD



Evidence continues to accumulate for the efficacy of tranexamic acid (TXA) use in primary total knee arthroplasty (TKA).   An essential question that remains is to determine which specific subgroups of patients undergoing TKA will benefit from TXA use and if surgeons should be more selective in its administration. We performed a retrospective cohort study involving 187 TKA patients who received intraarticular (“topical”) TXA, and compared these to 168 historical controls who did not receive TXA. These patients were then subdivided into groups based on gender, age, BMI, and preoperative hemoglobin for analysis. All patients, despite their demographics, saw an improvement in primary outcome measures without a detectable increase in complications.  Based on these data, there are no restrictions on the use of TXA. Obese patients, females, and those over 65 years of age undergoing total knee arthroplasty may benefit from TXA most consistently.


Seo J-G, Moon Y-W, Park S-H, Kim S-M, Ko K-R. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013 Aug;21(8):1869–74.

Chimento GF, Huff T, Ochsner JL, Meyer M. An Evaluation of the Use of Topical Tranexamic Acid in Total Knee Arthroplasty. The Journal of Arthroplasty. 2013 Sep 1;28(8):74.

Wind TC, Barfield WR, Moskal JT. The Effect of Tranexamic Acid on Blood Loss and Transfusion Rate in Primary Total Knee Arthroplasty. The Journal of Arthroplasty. 2013 Aug 1;28(7):1080.

Soni A, Saini R, Gulati A, Paul R, Bhatty S, Rajoli S reddy. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee replacement. The Journal of Arthroplasty [Internet]. [cited 2014 Apr 13]; Available from:

Alshryda S, Mason J, Vaghela M, Sarda P. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). The Journal of bone and joint surgery American volume. 2013 Nov 6;95(21):1961.

Sepah YJ, Umer M, Ahmad T, Nasim F, Umer Chaudhry M, Umar M. Use of Tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg Res [Internet]. 2011 May 21 [cited 2013 Aug 1];6:22.

Georgiadis, A. G., Muh, S. J., Silverton, C. D. & Weir, R. M. A Prospective Double-

Blind Placebo Controlled Trial of Topical Tranexamic Acid in Total Knee Arthroplasty.

The Journal of Arthroplasty 28, 78 (2013).

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost Benefit Analysis of Topical Tranexamic Acid in Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2014 Feb 3;

Lee, S. H., Cho, K.-Y., Khurana, S. & Kim, K.-I. Less blood loss under concomitant

administration of tranexamic acid and indirect factor Xa inhibitor following total knee

arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol

Arthrosc 21, 2611–2617 (2013).

Wong J, Abrishami W, El Behiery H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Joint Surg Am, 92 (2010), p. 2503.

Kuroda R, Ishida K, Tsumura N, et al. Intra-articular injection of tranexamic acid

reduces not only blood loss but also knee joint swelling after total knee arthroplasty

International Orthopaedics (SICOT)(2011)35:1639–1645.

Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: A systematic review and meta-analysis. The Knee. 2013 Oct 1;20(5).

Sa-Ngasoongsong P, Wongsak S, Chanplakorn P, Woratanarat P. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC musculoskeletal disorders. 2013;14:340.

Ritter MA, Wing JT, Berend ME, Davis KE. The Clinical Effect of Gender on Outcome of Total Knee Arthroplasty. The Journal of Arthroplasty. 2008;23(3):331–6.

Suleiman LI, Ortega G, Ong’uti SK, Gonzalez DO, Tran DD, Onyike A, et al. Does BMI Affect Perioperative Complications Following Total Knee and Hip Arthroplasty? Journal of Surgical Research [Internet]. 2012 May [cited 2013 Dec 20];174(1):7–11.

Kennedy JW, Johnston L, Cochrane L, Boscainos PJ. Total knee arthroplasty in the elderly: does age affect pain, function or complications? Clinical orthopaedics and related research. 2013 Jun 1;471(6):1964.

Friedman RJ, Butler JE, Zimlich RH, Del Schutte H. Preoperative hemoglobin as a predictor of transfusion risk in total hip and knee arthroplasty. The Journal of Arthroplasty. 1998;13(2):238.




How to Cite

Tuttle, MD, J., Anazonwu, BS, W., & Rubin, MD, L. (2014). Subgroup Analysis of Topical Tranexamic Acid in Total Knee Arthroplasty. Reconstructive Review, 4(2).



Original Article